ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

ClinicalTrials.gov ID: NCT05525520

Public ClinicalTrials.gov record NCT05525520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Study identification

NCT ID
NCT05525520
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Escient Pharmaceuticals, Inc
Industry
Enrollment
62 participants

Conditions and interventions

Conditions

Interventions

  • EP547 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 5, 2022
Primary completion
Jul 16, 2024
Completion
Sep 4, 2024
Last update posted
Jul 30, 2025

2022 – 2024

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
University of Alabama Birmingham Hospital Birmingham Alabama 35294
Dignity Health Center for Clinical Research at St. Joseph Hospital Phoenix Arizona 85013
Southern California Research Center Coronado California 92118
Science 37 Culver City California 90230
California Liver Research Institute Pasadena California 91105
University of Miami - Schiff Center for Liver Diseases Miami Florida 33136
University of Iowa Hospitals & Clinics Iowa City Iowa 52242
Tulane University Health Sciences Center New Orleans Louisiana 70112
Ochsner Medical Center New Orleans Louisiana 70121
Massachusetts General Hospital Boston Massachusetts 02114
University of Minnesota Minneapolis Minnesota 55455
NYU Grossman School of Medicine Gastroenterology and Hepatology New York New York 10016
Montefiore Medical Center The Bronx New York 10467
Gastro Health Research Cincinnati Ohio 45249
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
UPMC Center for Liver Disease Pittsburgh Pennsylvania 15213
The Liver Institute at Methodist Dallas Medical Center Dallas Texas 75203
Liver Associates of Texas, PA Houston Texas 77030
Gastro Health & Nutrition Katy Texas 77494
Digestive & Liver Disease Specialists Norfolk Virginia 23502
Bon Secours Liver Institute of Virginia Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05525520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05525520 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →